Literature DB >> 28115080

Observational Research Using Propensity Scores.

Karthik Raghunathan1, J Bradley Layton2, Tetsu Ohnuma2, Andrew D Shaw2.   

Abstract

In most observational studies, treatments or other "exposures" (in an epidemiologic sense) do not occur at random. Instead, treatments or other such interventions depend on several patient-related and patient-independent characteristics. Such factors, associated with the receipt vs nonreceipt of treatment, may also be-independently-associated with outcomes. Thus, confounding exists making it difficult to ascertain the true association between treatments and outcomes. Propensity scores (PS) represent an intuitive set of approaches to reduce the influence of such "confounding" factors. PS is a computed probability of treatment, a value that is estimated for each patient in an observational study and then applied (in a variety of ways such as matching, stratification, weighting, etc.) to reduce distortion in the true nature of the association between treatment (or any similar exposure) and outcomes. Despite several advantages, PS-based methods cannot account for unmeasured confounding, ie, for factors that are not being included in the computation of PS. Published by Elsevier Inc.

Entities:  

Keywords:  Propensity scores; RCTs

Mesh:

Year:  2016        PMID: 28115080     DOI: 10.1053/j.ackd.2016.11.010

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  4 in total

1.  Polypharmacy and medication use by cancer history in a nationally representative group of adults in the USA, 2003-2014.

Authors:  Christine D Hsu; Hazel B Nichols; Jennifer L Lund
Journal:  J Cancer Surviv       Date:  2021-05-25       Impact factor: 4.442

2.  Based on biomedical index data: Risk prediction model for prostate cancer.

Authors:  Hanxu Guo; Xianjie Jia; Hao Liu
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

3.  Hyperkalemia and its Association With Mortality, Cardiovascular Events, Hospitalizations, and Intensive Care Unit Admissions in a Population-Based Retrospective Cohort.

Authors:  Ingrid Hougen; Silvia J Leon; Reid Whitlock; Claudio Rigatto; Paul Komenda; Clara Bohm; Navdeep Tangri
Journal:  Kidney Int Rep       Date:  2021-03-17

4.  Drug interactions in hospital prescriptions in Denmark: Prevalence and associations with adverse outcomes.

Authors:  Cristina Leal Rodríguez; Benjamin Skov Kaas-Hansen; Robert Eriksson; Jorge Hernansanz Biel; Kirstine G Belling; Stig Ejdrup Andersen; Søren Brunak
Journal:  Pharmacoepidemiol Drug Saf       Date:  2022-02-22       Impact factor: 2.732

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.